Search for: "Perrigo Company"
Results 41 - 60
of 87
Sort by Relevance
|
Sort by Date
22 Dec 2011, 11:59 am
Here we go again. [read post]
10 Jun 2011, 6:43 am
., Emerson Electric Co. and Perrigo Co., told members of Congress that they would will be willing to give up tax breaks in exchange for a lower corporate tax rate. [read post]
6 Jun 2011, 9:00 pm
and Perrigo Co., a leading pharmaceutical manufacturer, said Thursday that they prefer the simplicity and certainty of a rate as low as 25% over the complexity of calculating frequently shifting tax breaks.[...] [read post]
18 May 2011, 12:33 am
Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
21 Mar 2011, 3:50 pm
The Perrigo defendants sought to dismiss these investors’ claims, arguing that their purchases of Perrigo shares on the TASE (as opposed to the NASDAQ) precluded their participation in the action under Morrison. [read post]
24 Jan 2011, 4:58 pm
Perrigo Pharmaceuticals Company (9th Cir. [read post]
4 Oct 2010, 1:54 am
Perrigo Company: As discussed here, the auction rate securities lawsuit filed against Perrrigo and certain of its directors and offices did not involve the usual allegations that an auction rate securities seller had misrepresented the securities in connection with the securities’ sale; rather, Perrigo was an auction rate securities investor, and the plaintiffs, Perrigo shareholders, alleged that the defendants had misrepresented the… [read post]
28 Sep 2010, 3:14 pm
Perrigo Co. et al. [read post]
7 Sep 2010, 6:10 pm
Perrigo Co (IPBiz) Norvir (Ritonavir) – US: Abbott’s HIV/AIDS drug patents challenged by PUBPAT (IP Watchdog) ReFacto (Moroctocog) and Xyntha (Antihemophilic factor) – US: Novartis drops one of three patents from ReFacto/Xyntha suit against Wyeth (Patent Docs) Strattera (Atomoxetine) – US: CAFC grants injunction pending disposition of Lilly v Actavis Elizabeth (Patent Docs) Valcyte (Valganciclovir) – US: Ranbaxy settles patent dispute with Roche over Valcyte… [read post]
23 Aug 2010, 6:31 am
The following is excerpted from an August 22, 2010 press release found at Melodika.net: Perrigo Company announced its filing with the U.S. [read post]
18 Aug 2010, 12:19 am
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
16 Aug 2010, 12:13 pm
Perrigo Company (Fed. [read post]
10 Aug 2010, 8:44 pm
General Coverage of anti-counterfeit policy debate varies widely across global media (IP Watch) WHO declares flu pandemic over; experts behind response to be revealed (IP Watch) Australia: TGA to implement alert system for new ARTG registrations (IP Whiteboard) EU: Final petition of the Advocate-General / Jodosulfuron- SPC for plant protection products (EPLAW) India: Parliamentary Committee on Health tables report on issues relating to availability of generic medicines (Spicy IP) Peru:… [read post]
5 Aug 2010, 11:06 pm
Drug companies make their wages off such sin. [read post]
17 Jun 2010, 6:57 am
Your company is making privacy claims! [read post]
16 Jun 2010, 3:02 pm
Perrigo Company et al. [read post]
14 Jun 2010, 12:16 pm
Perrigo Company et al., 2-10-cv-00937 (NJD June 10, 2010, Opinion) (Martini, J.) [read post]
7 Jun 2010, 7:21 pm
Karst – FDA's recent approval of an ANDA submitted by Perrigo R&D Company ("Perrigo") for a generic version of the over-the-counter drug MONISTAT 1 Combination Pack (1200 mg miconazole nitrate vaginal insert and 2% miconazole nitrate cream) contains some interesting language concerning 180-day exclusivity eligibility. [read post]
28 May 2010, 12:27 pm
Perrigo Pharms., Inc., 672 F. [read post]
27 May 2010, 9:36 am
” Back to Perrigo. [read post]
